AC Immune S.A.
- ACIU
- NASDAQ
- Biotechnology
- Biotech
- Healthcare
$2.44
Today +1.88%Quote Oct 19, 2026, 08:00 PM UTC
−7.22%over the last month
Max drawdown −15.5%From 1-month high −13.8%3 months +6.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About AC Immune
AC Immune S.A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegenerative conditions rooted in protein misfolding, both preventatively and therapeutically.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
106
Founded
2003
Market value
$247.8M
Quote Oct 19
Floor
$2.41
0.9% below price
Resistance
$2.48
1.7% above price
Price vs analyst targets
9 analysts
Lowest target
$7.00Highest target
$10.00
$7.00Highest target
$10.00
- Price $2.44
- Average target $8.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 242% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ACIUPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free